BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25820068)

  • 1. High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice.
    Zhang C; Ku Z; Liu Q; Wang X; Chen T; Ye X; Li D; Jin X; Huang Z
    Vaccine; 2015 May; 33(20):2335-41. PubMed ID: 25820068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
    Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L
    Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice.
    Zhang C; Liu Q; Ku Z; Hu Y; Ye X; Zhang Y; Huang Z
    Antiviral Res; 2016 May; 129():47-51. PubMed ID: 26902108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
    Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
    Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
    Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
    Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z
    Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.
    Wang Z; Zhou C; Gao F; Zhu Q; Jiang Y; Ma X; Hu Y; Shi L; Wang X; Zhang C; Liu B; Shen L; Mao Q; Liu G
    Vaccine; 2021 Jul; 39(31):4296-4305. PubMed ID: 34167837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges.
    Yan Q; Wu L; Chen L; Qin Y; Pan Z; Chen M
    Vaccine; 2016 Jul; 34(35):4196-4204. PubMed ID: 27373596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.
    Zhang C; Zhang X; Zhang W; Dai W; Xie J; Ye L; Wang H; Chen H; Liu Q; Gong S; Geng L; Huang Z
    Emerg Microbes Infect; 2018 Jan; 7(1):3. PubMed ID: 29323105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.
    Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z
    Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.
    Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX
    Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
    Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice.
    Zhou Y; Shen C; Zhang C; Zhang W; Wang L; Lan K; Liu Q; Huang Z
    Antiviral Res; 2016 Aug; 132():165-9. PubMed ID: 27315772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
    Li HY; Han JF; Qin CF; Chen R
    Vaccine; 2013 Jul; 31(32):3281-7. PubMed ID: 23726823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.